Trial site
Xuchang Central Hospital
Xuchang, Henan 461000, ChinaNot linked to an institution yet
The trials here
What the 9 trials at this site are about, from their registry records.
- Phase
- Phase 33 trials
- Phase 21 trial
- Status
- Recruiting5 trials
- Not yet recruiting4 trials
- Lead sponsor
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd.3 trials
- The First Affiliated Hospital of Zhengzhou University2 trials
- Beijing 302 Hospital1 trial
- Beijing Tiantan Hospital1 trial
- GeneQuantum Healthcare (Suzhou) Co., Ltd.1 trial
- and 1 more
Running trials
Recruiting
A Clinical Trial on the Efficacy and Safety of TQH3906 in the Treatment of Systemic Lupus Erythematosus
NCT07509892· Phase 2· Chia Tai Tianqing Pharmaceutical Group Co., Ltd.· Source
Contact: Weitao Yang, Master
Recruiting
A Prospective, Multicenter, Randomized Controlled Trial Investigating the Impact of Fasting Duration on Postoperative Rebleeding Following Esophageal Variceal Ligation.
NCT07774143· The First Affiliated Hospital of Zhengzhou University· Source
Contact: Weihong Li
Not yet recruiting
A Real-World Study of Antiviral Therapy in Children With Chronic Hepatitis B
NCT06926647· Beijing 302 Hospital· Source
Contact: Weihong Li
Recruiting
A Study of TQB3473 Tablets Compared to Placebo in the Treatment of Adult Primary Immune Thrombocytopenia
NCT06900920· Phase 3· Chia Tai Tianqing Pharmaceutical Group Co., Ltd.· Source
Contact: Shuhao Mei, Master
Recruiting
A Trial Comparing GQ1005 and T-DM1 in Patients With HER2-Positive Unresectable or Metastatic Breast Cancer
NCT07673029· Phase 3· GeneQuantum Healthcare (Suzhou) Co., Ltd.· Source
Contact: Ping Li
Recruiting
Observation Study on Reducing the Risk of Liver Cancer Associated With Hepatitis B (Zhiyuan) Project.
NCT07169656· The First Affiliated Hospital of Zhengzhou University· Source
Contact: Weihong Li
Recruiting
D-1553 Tablet Versus Docetaxel Injection for KRAS G12C Mutation-positive Locally Advanced or Metastatic Non-small Cell Lung Cancer After Prior Standard Therapy Failure
NCT06300177· Phase 3· Chia Tai Tianqing Pharmaceutical Group Co., Ltd.· Source
Contact: Pengyuan Wang, Master
Recruiting
Epidemiological Investigation of Helicobacter Pylori-infected Patients and the Effect of Eradication Treatment on Dyspepsia Symptoms
NCT06422052· Shanghai Jiao Tong University School of Medicine· Source
Contact: Shilei Song
Recruiting
China HeadAche DIsorders RegiStry
NCT05334927· Beijing Tiantan Hospital· Source
Contact: Yong Gang Wang, Doctor
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
Report an error